Stephen J Tulipano Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen J Tulipano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen J Tulipano. Stephen J Tulipano is CFO and Secretary in JAVELIN PHARMACEUTICALS, INC ($ITRD) and Chief Financial Officer in JAVELIN PHARMACEUTICALS, INC ($ITRD) and Chief Financial Officer in Aldeyra Therapeutics, Inc. ($ALDX) and CFO in Stoke Therapeutics, Inc. ($STOK).
Latest Insider Trading Transactions of Stephen J Tulipano
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDX, ITRD, STOK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 5,000 | 22,400 | 179,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 25,000 | 112,000 | 184,997 | |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.60 | 5,000 | 292,992 | 602 | 5.6 K to 602 (-89.25 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 5,000 | 22,400 | 5,602 | 602 to 5.6 K (+830.56 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 60.00 | 102 | 6,120 | 602 | 704 to 602 (-14.49 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 59.29 | 9,696 | 574,842 | 704 | 10.4 K to 704 (-93.23 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.67 | 15,202 | 891,942 | 10,400 | 25.6 K to 10.4 K (-59.38 %) |
| Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 25,000 | 112,000 | 25,602 | 602 to 25.6 K (+4,152.82 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 33,268 | 149,041 | 209,997 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 1,732 | 7,759 | 243,265 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 35,000 | 156,800 | 244,997 | |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 41.97 | 5,216 | 218,910 | 602 | 5.8 K to 602 (-89.65 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 41.42 | 11,111 | 460,214 | 5,818 | 16.9 K to 5.8 K (-65.63 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 40.03 | 16,941 | 678,086 | 16,929 | 33.9 K to 16.9 K (-50.02 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 33,268 | 149,041 | 33,870 | 602 to 33.9 K (+5,526.25 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 39.84 | 1,732 | 68,998 | 602 | 2.3 K to 602 (-74.21 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 1,732 | 7,759 | 2,334 | 602 to 2.3 K (+287.71 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 38.44 | 400 | 15,374 | 602 | 1 K to 602 (-39.92 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 37.86 | 14,445 | 546,909 | 1,002 | 15.4 K to 1 K (-93.51 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 36.79 | 20,155 | 741,448 | 15,447 | 35.6 K to 15.4 K (-56.61 %) |
| Nov 04 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 35,000 | 156,800 | 35,602 | 602 to 35.6 K (+5,813.95 %) |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 20.25 | 60,000 | 1,215,000 | 60,000 | |
| Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Option Exercise | A | 8.60 | 125,670 | 1,080,762 | 125,670 | |
| Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Grant | A | 4.00 | 3,153 | 12,596 | 8,563 | 5.4 K to 8.6 K (+58.28 %) |
| Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Grant | A | 3.95 | 2,077 | 8,209 | 5,410 | 3.3 K to 5.4 K (+62.32 %) |
| Mar 07 2017 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Option Exercise | A | 5.10 | 220,980 | 1,126,998 | 220,980 | |
| Feb 21 2017 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Buy | P | 4.50 | 3,333 | 14,999 | 3,333 | 0 to 3.3 K |
| Mar 18 2016 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Option Exercise | A | 4.59 | 30,000 | 137,700 | 30,000 | |
| Jun 05 2015 | ALDX | Aldeyra Therapeuti ... | Tulipano Stephen J | Chief Financial Off ... | Option Exercise | A | 7.85 | 25,000 | 196,250 | 25,000 | |
| May 05 2010 | ITRD | JAVELIN PHARMACEUT ... | Tulipano Stephen J | CFO and Secretary | Sell | S | 2.18 | 2,385 | 5,200 | 22,615 | 25 K to 22.6 K (-9.54 %) |
| Dec 22 2009 | ITRD | JAVELIN PHARMACEUT ... | Tulipano Stephen J | CFO and Secretary | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| May 05 2009 | ITRD | JAVELIN PHARMACEUT ... | Tulipano Stephen J | CFO and Secretary | Option Exercise | A | 1.26 | 75,000 | 94,500 | 75,000 | |
| May 05 2009 | ITRD | JAVELIN PHARMACEUT ... | Tulipano Stephen J | CFO and Secretary | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jan 05 2007 | ITRD | JAVELIN PHARMACEUT ... | Tulipano Stephen J | Chief Financial Off ... | Option Exercise | A | 4.98 | 45,000 | 224,100 | 45,000 |
Page: 1